Datta Mamta R, Ghosh Mousumi D, AyazAhmed Kharodiya Zainab
Obstetrics and Gynecology, Tata Main Hospital, Jamshedpur, IND.
Obstetrics and Gynecology, Tata Main Hospital, Manipal Tata Medical College, Jamshedpur, IND.
Cureus. 2023 Nov 26;15(11):e49422. doi: 10.7759/cureus.49422. eCollection 2023 Nov.
Introduction Misoprostol (prostaglandin E1 analog) is being used for the induction of labor by vaginal, oral, and sublingual routes. Oral misoprostol is the preferred route for induction of labor, but the use of sublingual misoprostol appears promising due to a faster onset of action. This study was done to compare the efficacy and safety of oral and sublingual misoprostol for induction of labor in term pregnancy. Materials and methods One hundred and sixty patients were randomly allocated to one of the two groups to receive 50 micrograms of oral and sublingual misoprostol four hourly for a maximum of six doses. Primigravida at 37-42 weeks of gestation with singleton pregnancy, cephalic presentation, Bishop score (<5), and reassuring fetal heart rate were included in the study. Misoprostol dose was withheld if the active phase of labor was reached or if the cervix was favorable for amniotomy (Bishop score greater than or equal to eight). The change in the Bishop score with misoprostol was studied along with adverse effects and neonatal outcomes. Results The mean number of 50 mcg misoprostol doses required was significantly less in the sublingual group (2.94±0.97 versus 2.13±0.92; p<0.0001). The rate of change of the mean Bishop score was faster in the sublingual group. After four hours of the first dose, the mean Bishop score changed to 3.52±2.14 versus 4.68±2.34 (p=0.001), and, similarly, after eight hours, it was 10.48±2.59 versus 11.39±2.06, and this difference was statistically significant (p=0.015). The mean induction delivery interval was significantly lower in the sublingual group. The need for labor augmentation, mode of delivery, and adverse effects were similar in both groups. The incidence of meconium-stained liquor and NICU admission was also similar in both groups. Conclusion Sublingmisoprostolstol has a short induction delivery interval and comparable side effects when compared to omisoprostolstol. Sublingmisoprostolstol is recommended for induction of labor at term.
引言 米索前列醇(前列腺素E1类似物)正通过阴道、口服和舌下途径用于引产。口服米索前列醇是引产的首选途径,但舌下含服米索前列醇由于起效更快似乎很有前景。本研究旨在比较口服和舌下含服米索前列醇在足月妊娠引产中的疗效和安全性。
材料与方法 160例患者被随机分配到两组中的一组,每4小时接受50微克口服和舌下含服米索前列醇,最多6剂。纳入研究的对象为妊娠37 - 42周的初产妇,单胎妊娠,头先露,Bishop评分(<5),胎儿心率正常。如果进入产程活跃期或宫颈条件适合人工破膜(Bishop评分大于或等于8),则停用米索前列醇。研究米索前列醇使用后Bishop评分的变化以及不良反应和新生儿结局。
结果 舌下含服组所需50微克米索前列醇的平均剂量显著更少(2.94±0.97对2.13±0.92;p<0.0001)。舌下含服组平均Bishop评分的变化率更快。首剂用药4小时后,平均Bishop评分变为3.52±2.14对4.68±2.34(p = 0.001),同样,8小时后,分别为10.48±2.59对11.39±2.06,差异具有统计学意义(p = 0.015)。舌下含服组平均引产至分娩间隔显著更短。两组在产程加强需求、分娩方式及不良反应方面相似。两组羊水粪染和新生儿重症监护病房收治率也相似。
结论 与口服米索前列醇相比,舌下含服米索前列醇引产至分娩间隔短且副作用相当。推荐舌下含服米索前列醇用于足月引产。